{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoOny8f8LDA","lastupdate":"2022-11-08T00:00:00.000Z","update_date":"2022-11-08T00:00:00.000Z","lastModified":"Apr 24, 2025","active":1,"confidence_score":90,"confidence_score_reason":"founding month, funding rounds, markets, not claimed","urlname":"cannassure","minimal_profile":null,"status":"Public","fullstatus":"Public on TASE on Dec, 2018;","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$904PtYEnnt0ZW7cSU62taLiRfnmDsW4i5XsBXHnm6QZCtDIioxb3l8","name":"CannAssure Therapeutics","oneliner":"Medical Cannabis Products","registrar":"515761138","website":"http://www.cannassure.life/","careerspage":"https://www.cannassure.life/careers","founded_month":1,"founded_year":2016,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCXKUrgTKAeMkClylZKg9nJg","facebook":"https://www.facebook.com/Cannassure-1808292219297130","linkedin":"https://www.linkedin.com/company/18300557","instagram":"https://www.instagram.com/cannassure"},"social":["https://www.facebook.com/Cannassure-1808292219297130","https://www.youtube.com/channel/UCXKUrgTKAeMkClylZKg9nJg","https://www.linkedin.com/company/18300557","https://www.instagram.com/cannassure"],"flattenedsociallinks":"https://www.facebook.com/Cannassure-1808292219297130|https://www.youtube.com/channel/UCXKUrgTKAeMkClylZKg9nJg|https://www.linkedin.com/company/18300557|https://www.instagram.com/cannassure","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"1-10","employees_exact":8,"patent":1,"raised":3435000,"stage":"Public","public_stage":"Public","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Cann-Assure","Solbar Food Technologies","Cann Assure","Cann.Assure"],"about":"Cannassure develops and commercializes a wide range of effective, high-quality, affordable medical cannabis products and pharmaceutical cannabinoid medicines designed to enhance treatment and improve the quality of life for people worldwide.\r\n\r\nThe company ensures the highest standards by facilitating a holistic integrated production system, including a clean and controlled and advanced indoor aeroponic grow facility and an extraction and processing facility, along with scientifically advanced research and development.\r\n\r\nCannassure operates in accordance with IMC-GAP standards, testing both its unprocessed cultivated cannabis and its manufactured products at different stages of production to ensuring purity, effectiveness, stability, and consistency for the duration of the products shelf life.\r\n\r\nCannasure is a spinoff of food manufacturer Solbar Food Technologies, with 60 years of applied industrial expertise and know-how. Solbar is the majority shareholder in the company.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97223122018","country":null,"address":{"israeli":[{"id":"3ee9b6be-e4de-4400-8d28-f43061793fee","city":"Ashdod","type":null,"address":"HaHadarim Street 2, Ashdod, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"South District","news":[{"id":"e44f8d6d-c245-4e92-af43-d382a91642f4","date":"Feb 20, 2022","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2109903_0_Txtetaxjxdshwhus8sp&ArticleId=107751","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"exclusive agreement","company":"קנאשור תראפיוטיקס","layoffs":null,"summary":"קנאשור תראפיוטיקס, a leading indoor company in Israel, has signed an exclusive agreement for the cultivation, marketing, and sale of the successful Freud Super Ego strain. The agreement covers all products based on the Freud strain or its flower. The company is in the process of expanding its cultivation of the strain, which began at its facility in Ashdod. RCK, a technology developer for the development and cultivation of new cannabis strains, is closely collaborating with קנאשור תראפיוטיקס. The agreement is seen as an important milestone in the fruitful cooperation between the companies over the past two years and contributes to the development strategy of RCK through partnerships with quality growers.","partners":"RCK","customers":null,"investors":null,"confidence":8,"key_topics":["קנאשור תראפיוטיקס","זן פרויד","RCK","הסכם בלעדיות","גידול"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bmxQ3f22GZkxR3Hnr9sm6wmdfS6FYZo1vKljletdsbo5SA9LfSg2yO","news_summary":"קאנשור משיגה בלעדיות על זן פרויד","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"06d9cd40-a5e7-4e8c-ad65-a0eb2d0c4aab","date":"Nov 22, 2021","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2035983_0_Txtetaxjxdshwhus8sp&ArticleId=106942","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"partnership","company":"Provacan","layoffs":null,"summary":"Provacan, a popular brand in the UK, is expected to begin its marketing in the first quarter of 2022. Provacan has announced a partnership agreement with CiiTECH for the production and distribution of cannabis oils in Israel. The cannabis consumer market in Israel is growing steadily, and the partnership aims to educate users about the effectiveness of CiiTECHs oils compared to smoking flowers. The companies will provide courses for Provacan ambassadors and users to promote the use of CiiTECH and Provacan products. The partnership is expected to bring value to both companies and the cannabis market in Israel.","partners":"CiiTECH","customers":null,"investors":null,"confidence":8,"key_topics":["Provacan","CiiTECH","cannabis","Israel","partnership"],"date_of_event":"2021-11-22","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pUwqXglr1Ytbeks3585JasRnc1G3QzVvZWWyOO6IUR832VQQyNq6YS","news_summary":"קנאשור ו- CiiTECH ישווקו את שמני המותג Provacan בישראל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fe1e0185-1db0-46da-bc05-d1d4deb7d7af","date":"Sep 9, 2021","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_1953548_0_Txtetaxjxdshwhus8sp&did=1001384017","source":"www.globes.co.il","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"rV8fOBEuEkEiMJ82HbGPv3tG8nJ01bTnQIzhexQBeBaVpctJt2QhIB","news_summary":"יו\"ר קאנשור עידו נחושתן עוזב. האם זה קשור לתנאי השכר שלו?","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"32b94727-e934-44e5-ad1b-8acbc966eab8","date":"Aug 9, 2021","link":"https://www.prnewswire.com/news-releases/cannassure-was-granted-a-patent-for-an-oral-delivery-method-of-cannabis-and-cannabinoids-compositions-by-the-israel-patents-authority-301350927.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical cannabis","company":"Cannassure Therapeutics Ltd","layoffs":null,"summary":"Cannassure Therapeutics has been granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. The companys innovative technology allows for the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract. This new delivery system provides alternative methods of administration and swallowable products, expanding access to cannabis-based treatments for new patient populations. The patent approval gives Cannassure a competitive advantage in the global market for swallowable cannabis products. The company plans to seek regulatory approval for testing the effectiveness of their products for pain relief in humans and continue developing and commercializing a wide range of innovative medical cannabis products.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["patent","oral delivery method","medical cannabis products","global market","product development"],"date_of_event":"2021-08-09","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"W5oQu2rDyoDSNnIlxm8zWgBICHfmkAtscVgf32fCvKZ5cB3gsMhAlh","news_summary":"Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d923874b-e3db-4938-ad7b-f2e6cfd4fa09","date":"Jan 18, 2021","link":"https://news.cision.com/dancann-pharma/r/dancann-pharma-s-strategic-partner--cannassure-therapeutics-ltd--enter-exclusive-licensing-agreement,c3269665","source":"news.cision.com","visible":1,"analysis":{"tags":["licensing agreement","partnership","distribution agreement","medical cannabis","pharmaceuticals"],"company":"DanCann Pharma A/S","layoffs":null,"summary":"DanCann Pharma announces that its strategic partner, Cannassure Therapeutics, has signed an exclusive licensing agreement with Lipidor AB for the use of AKVANO® technology in medicinal cannabis products. DanCann Pharma is the exclusive distributor of Cannassures product portfolio in Scandinavia. The agreement allows Cannassure to develop products for the non-prescription and prescription markets, while Lipidor retains the right to develop cannabis-related products in other indications. The market for topical therapies in the covered indications is expected to exceed USD 50 billion by 2027. DanCann Pharma also has a distribution agreement with Cannassure to expand its product portfolio in cannabinoid-based pharmaceuticals. The company plans to submit its first product approval application in early 2021. The CEOs of both DanCann Pharma and Cannassure express excitement about the partnership and the potential for innovative cannabis treatments.","partners":["Cannassure Therapeutics Ltd.","Lipidor AB"],"customers":null,"investors":null,"confidence":9,"key_topics":["licensing agreement","product portfolio","medical cannabis","AKVANO® technology","distribution agreement"],"date_of_event":"2021-01-18","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"L4AiQglib1wqsyCQ2Y1hHjU8G9pXtx1at6wN37ZCJAekQAdXsl09sD","news_summary":"DanCann Pharma's strategic partner, Cannassure Therapeutics Ltd., enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"accdd533-4b9a-4cf3-94b7-75df9a325c24","date":"Jan 7, 2021","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_1728657_0_Txtetaxjxdshwhus8sp&ArticleId=103304","source":"www.sponser.co.il","visible":1,"analysis":{"tags":["medical cannabis"],"company":"קנאשור","layoffs":null,"summary":"Medical cannabis company Kanashur has completed a stock offering worth approximately 10 million NIS. The company received excess demand of 1.5 times the offering amount, totaling around 17 million NIS. The proceeds from the offering will support the companys ongoing activities. Kanashur also announced sales forecasts of approximately 34 million NIS for 2021 and is in advanced discussions with several growers in Israel for processing, manufacturing, and packaging services. Additionally, the company is working on an exclusive license agreement for the global use of Lipidor technology combined with cannabis and cannabinoids for the production of products. Kanashur recently completed a successful feasibility study for a medical device based on cannabinoids for local treatment of inflammatory skin diseases.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["stock offering","sales forecast","partnership","product development","medical cannabis"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SccLxoyAKrXUS9MMq00yIkUXAGejwG23tLivUNN49ro8Cqe6oh3wWH","news_summary":"קנאשור השלימה הנפקת מניות בהיקף של כ-10 מיליון שקל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"96d3bb94-d3b6-4920-ba79-e5a04fa164f3","date":"Dec 15, 2020","link":"https://www.prnewswire.com/news-releases/cannasure-and-dancann-pharma-sign-an-exclusive-distribution-agreement-for-denmark-norway-sweden-and-finland-301193356.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"distribution agreement","company":"Cannassure Therapeutics Ltd","layoffs":null,"summary":"Cannassure Therapeutics has signed an exclusive distribution agreement with DanCann Pharma to distribute its medical cannabis products in Denmark, Norway, Sweden, and Finland. The agreement aligns with Cannassures strategy of expanding its business and pipeline. The CEO of DanCann Pharma expressed excitement about the partnership and the opportunity to provide patients with alternative treatment options. Cannassure is a leading developer and provider of medical cannabis products, while DanCann Pharma is a Danish pharmaceutical biotechnology company focused on cannabinoids. The specific products and branding will be determined mutually by both parties. The distribution agreement is expected to benefit both companies and patients in Scandinavia, with the products set to launch in 2021.","partners":["DanCann Pharma"],"customers":null,"investors":null,"confidence":9,"key_topics":["Cannassure","DanCann Pharma","distribution agreement","medical cannabis products","Scandinavia"],"date_of_event":"2020-12-15","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"omzzBLpvk5vxKNm24XwX10dbCVv9XmS0PHicKN61BdbJD4MxJFMPqr","news_summary":"Cannasure and DanCann Pharma sign an exclusive distribution agreement for Denmark, Norway, Sweden and Finland","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5762225d-a4f4-4f41-a89d-296d92da7dfa","date":"Dec 9, 2020","link":"https://www.sponser.co.il/Article.aspx?ArticleId=102957","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"export, medical cannabis, partnership","company":"קנאשור","layoffs":null,"summary":"Israeli medical cannabis company, Cannasure, has exported its Cannasure Drops to France for the first time as part of a pilot program for medical cannabis. The company has also signed a memorandum of understanding with a French pharmaceutical company for collaboration in the pilot program. The pilot program in France will be conducted by the National Agency for Medicines Safety (ANSM), and the cannabis oils sent will be tested in ANSM laboratories. Cannasure Drops are based on botanical extracts from Cannasures facility and are intended for sublingual use. The company sees this export as a significant milestone and a step towards its development in Europe.","partners":["Pharma"],"customers":null,"investors":null,"confidence":8,"key_topics":["export","medical cannabis","partnership","France","Cannasure Drops"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rvVlDBdPpKcUxvmUt3EkRDj9AL4YTvky0qPfLxSCU2RcGZfUPgHrvt","news_summary":"קנאשור ייצאה לראשונה לצרפת שמן קנאביס","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2d8d1fbe-207f-4d1d-b983-56ec99e1fb2f","date":"Sep 30, 2020","link":"https://www.prnewswire.com/news-releases/successful-completion-of-feasibility-study-for-the-development-of-topical-medical-cannabis-products-based-on-akvano-technology-301141616.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical cannabis","company":"Cannassure Therapeutics Ltd","layoffs":null,"summary":"Cannassure Therapeutics has successfully completed a feasibility study for the development of topical medical cannabis products for the treatment of skin inflammation. The study was conducted in collaboration with Lipidor AB, a Swedish topical drug development company. The development project is partially funded by the Israeli Innovation Authority. The product under development combines cannabinoids with Lipidors AKVANO® technology for localized administration and optimal penetration into the skin. Cannassure intends to negotiate an exclusive global license for the use of Lipidors technology. The global market for psoriasis treatment products is expected to reach $21.1 billion by 2021. Cannassures focus on developing innovative medical cannabis products aligns with its strategy.","partners":["Lipidor AB"],"customers":null,"investors":null,"confidence":9,"key_topics":["feasibility study","topical medical cannabis products","skin inflammation","AKVANO®","collaboration"],"date_of_event":"2020-09-30","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3ha2n951GjIzMPPtu0hfED40MmiY35wfIaWcRJKZ3nvJiMWJu1og6Y","news_summary":"Successful completion of feasibility study for the development of topical medical cannabis products based on AKVANO® technology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3246d3ad-e3ee-4788-a03c-98238c9d48bc","date":"Mar 17, 2020","link":"https://cannassure.life/site_media/novolog-logistics-will-distribute-cannassures-products-in-israel/","source":"cannassure.life","visible":1,"analysis":{"tags":"distribution agreement","company":"Cannassure","layoffs":null,"summary":"Cannassure has selected Novolog Logistics to distribute their medical cannabis products to pharmacies and medical cannabis dispensaries in Israel. This distribution agreement is a milestone for Cannassures goals and product delivery in Israel.","partners":["Novolog Logistics"],"customers":null,"investors":null,"confidence":9,"key_topics":["Cannabis products","Distribution","Pharmacies","Medical cannabis dispensaries","Novolog Logistics"],"date_of_event":"March 17, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jlTydYUbnq0W8QJc4MDuRtoJFQntENj1iewNrk4heiIF1irbwS1Q73","news_summary":"Novolog Logistics Will Distribute Cannassure's Products in Israel - Cannassure Therapeutics","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8f6fadf0-f3e4-4417-98f6-6ae422c7cb5a","date":"Dec 11, 2019","link":"https://www.prnewswire.com/news-releases/cannassure-therapeutics-ltd-and-lipidor-ab-enter-a-feasibility-study-and-licence-option-agreement-for-development-and-sales-of-topical-medical-cannabis-products-based-on-akvano-technology-300973434.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"joint development","company":"Cannassure Therapeutics Ltd","layoffs":null,"summary":"Cannassure Therapeutics has signed an agreement with Lipidor AB for the joint development of topical medical cannabis products. The agreement involves evaluating the feasibility of incorporating active pharmaceutical ingredients from the cannabis plant in Lipidors proprietary drug delivery platform technology. If the feasibility study is successful, Cannassure will have the option to enter an exclusive global license for the use of Lipidors technology. The joint ambition is to introduce innovative products for topical treatments in the growing global market for medical cannabis. The feasibility study is expected to conclude in Q3 2020.","partners":["Lipidor AB"],"customers":null,"investors":null,"confidence":9,"key_topics":["medical cannabis","topical treatments","drug delivery platform","feasibility study","global market"],"date_of_event":"December 11, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ozhlkEWN56PM0Ziw37yQ2zkEwFc1Rmd0SoLUSyom1YfIr1Hs4qeq1A","news_summary":"Cannassure Therapeutics Ltd and Lipidor AB Enter a Feasibility Study and Licence Option Agreement for Development and Sales of Topical Medical Cannabis Products Based on AKVANO Technology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"feae48f2-33e3-43b3-87cc-ef346d3b43c1","date":"Aug 18, 2019","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3768490,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"medical cannabis","company":"Cannassure Therapeutics Ltd.","layoffs":null,"summary":"Former Teva Pharmaceutical executive Yafit Stark has joined the scientific advisory committee of Cannassure Therapeutics. Starks knowledge and experience will help Cannassure establish itself as a leader in research and development. Cannassure is currently setting up an indoor cannabis greenhouse in Israel and has purchased 12,000 plants from Israeli cannabis company RCK. The company has also received a grant from the Israel Innovation Authority for a CBD extraction venture and expects to start selling oils and extracts in Q1 2020.","partners":["RCK (Israeli cannabis company)","Israel Innovation Authority"],"customers":null,"investors":null,"confidence":9,"key_topics":["Yafit Stark","Cannassure Therapeutics","medical cannabis","research and development","CBD extraction"],"date_of_event":"August 19, 2018","valuation_amount":"$18.1 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9sZlxL7ks0mXcbLfDsLzRPLFhxplpcU6BVdDmEKKjSc0iTd7Wf4LH4","news_summary":"Senior Teva R&D Executive Joins Cannabis Company Cannassure","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bbc48f9b-0be8-493f-b55e-ff4f0e042bff","date":"Jan 30, 2019","link":"https://www.newswire.ca/news-releases/cannassure-therapeutics-announces-strategic-partnership-with-cannika-holdings-863611628.html","source":"www.newswire.ca","visible":1,"analysis":{"tags":"collaboration, cannabis innovation","company":"Cannassure Therapeutics","layoffs":null,"summary":"Cannassure Therapeutics announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation. The collaboration will provide medical cannabis start-ups with a complete R&D ecosystem to advance cannabis-related initiatives. Cannassure will offer its facilities and expertise to support early-stage cannabis initiatives. Cannika will establish an independent fully licensed R&D facility with the partnership. Cannassure is a subsidiary of Solbar Food Technologies and holds all the approvals required for establishing a vertically integrated medical cannabis operation.","partners":"Cannika Holdings","customers":null,"investors":null,"confidence":9,"key_topics":["Cannassure","Cannika Holdings","collaboration","medical cannabis","R&D ecosystem"],"date_of_event":"January 30, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NCk9ZbTSvtIEuUFyo00ngYIoHyKIALwJidGWNSEWYpWsB3H819pCEY","news_summary":"Cannassure Therapeutics Announces Strategic Partnership With Cannika Holdings","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8abcb031-472c-4f07-b994-97dce3e6ade5","date":"Dec 23, 2018","link":"https://www.jpost.com/jpost-tech/cannassure-from-soybean-extraction-to-medical-cannabis-575141","source":"www.jpost.com","visible":1,"analysis":{"tags":"cannabis, medical cannabis, indoor growing","company":"Cannassure Therapeutics","layoffs":null,"summary":"Cannassure Therapeutics, an Ashdod-based company, is constructing a state-of-the-art indoor cannabis growing facility. The company, an offshoot of Solbar Food Technologies, has expertise in botanical extraction from its soybean extraction business. They are focusing on producing high-quality cannabis oil extractions using indoor growing methods, which provide consistency and stability. Cannassure has signed a strategic distribution agreement with Hadassah Medical to become their exclusive supplier of medical cannabis oil. While waiting for the approval of medical cannabis exports in Israel, Cannassure is exploring other European locations for potential operations and exports.","partners":"Hadassah Medical","customers":"Hadassah Medical","investors":null,"confidence":8,"key_topics":["Cannassure Therapeutics","indoor growing","medical cannabis","exports","European locations"],"date_of_event":"December 23, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kO3fakb8p0IiSTdUKfU1Mcf44sYWZEMagVWCiyymeAScf57ZdlsL73","news_summary":"https://www.jpost.com/jpost-tech/cannassure-from-soybean-extraction-to-medical-cannabis-575141","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":14,"techcommunityinvolvement":null,"mediagallery":[{"id":"bf297357-078c-4937-8901-06202429118c","timestamp":"2021-01-11 14:47:57.000000","resources_type":1,"resources_title":"Cannassure2","resources_file_name":"$Cf9G2aLmZMgSUEHVzPkSZEFfT2xC7gUjcxe5BmB9XdG6SO2YjNR37p","alt":"Cannassure2 logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$Cf9G2aLmZMgSUEHVzPkSZEFfT2xC7gUjcxe5BmB9XdG6SO2YjNR37p","url":"https://storage.googleapis.com/clean-finder-353810/$Cf9G2aLmZMgSUEHVzPkSZEFfT2xC7gUjcxe5BmB9XdG6SO2YjNR37p"},{"id":"ba4b5d09-3887-414c-88c9-9c0d16e17797","timestamp":"2020-10-04 09:47:54.000000","resources_type":2,"resources_title":"nir peles israel360","resources_file_name":"TroHuA1qX4Y","alt":"nir peles israel360 logo","imageurl":"https://img.youtube.com/vi/TroHuA1qX4Y/0.jpg","url":"http://youtu.be/TroHuA1qX4Y"},{"id":"082a8926-bd80-4faf-a9fd-17ca62de611d","timestamp":"2020-10-04 09:42:35.000000","resources_type":2,"resources_title":"CannAssure Video May 2020 ","resources_file_name":"8tGATtUrMJs","alt":"CannAssure Video May 2020  logo","imageurl":"https://img.youtube.com/vi/8tGATtUrMJs/0.jpg","url":"http://youtu.be/8tGATtUrMJs"}],"tags":["pharmaceuticals","seeds","cannabis","medical-products","medical-cannabis","drug-delivery","women-health","patients","indoor-farming","topical-treatment","dermatology","oral-drugs","anti-inflammatory"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B2C","B2B"],"productstage":"Released","products":["Cannassure Drops","Cannassure Select Inflorescences","Cannassure Indoor Inflorescences"],"geomarkets":["France","Sweden","Denmark","Israel","Norway","Finland"],"targetmarkets":[],"marketcapital":59801,"marketcapitaldate":"2023-08-01T22:00:23.000Z","funding":{"investors":0,"lastfunding":"$235K","totalrounds":2,"fundingstage":"Public","totalfunding":"$3.44M","publicinvestors":0,"lastpublicfunding":235000,"totalpublicrounds":2,"totalpublicfunding":3435000},"team":[{"name":"Nir   Peles","email":"nir.peles@cannassure.life","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOnM360LDA","bounced":false,"claimed":0,"founder":1,"urlname":"nir-peles","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg6ZvrtAgM","position":"Founder & Board Member ","last_name":"Peles","claimtoken":"HbepTWT2n5RjHcOidY0OiKoGkccsXMM40CLwdWaOznpW6knLzRApvl","first_name":"Nir  ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/nirpeles/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-08 14:47:08.000000","initials":"NP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ada Bar Kama","email":"ada.barkama@cannassure.life","phone":"","gender":"Female","userid":"9U3411LufNRUpde9OqoVRnbvFaSoV6WKneSXW94ow86HNMFmnz5WA8","bounced":true,"claimed":null,"founder":0,"urlname":"ada-bar-kama","visible":1,"memberid":"PFzfTV1ZK50nAWuc5KncEgnD3J7ZTzUUIkguWA1K0rbg7qRwGqgDV7","position":"CEO","last_name":"Bar Kama","claimtoken":"lcY4V5aXfSHk7pV25GHwN87glIYebAX4TeTJa4NPDIdFDNDKO8Wv0d","first_name":"Ada","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-11-08 14:50:24.000000","initials":"AB","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Steven  Eitan","email":"steven.eitan@cannassure.life","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LPKqtQLDA","bounced":true,"claimed":0,"founder":0,"urlname":"steven-eitan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgi5T52ggM","position":"VP Strategy","last_name":" Eitan","claimtoken":"f022a0fb741cad2fa58fb35b6c62431c1ffa0d33e153835f75b4a5738fbc2713","first_name":"Steven","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/steven-eitan-7ab9307/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-11 15:42:12.000000","initials":"S ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shimon  Barkama","email":"shimon.barkama@cannassure.life","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Mvo0_QIDA","bounced":true,"claimed":0,"founder":0,"urlname":"shimon-barkama","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgy8ObswkM","position":"Director","last_name":"Barkama","claimtoken":"Zj31UwnI9wWygcJpSVzmbQ6Sp3r0CMWGZK3JYqMyxW4BsAHmeqzxxN","first_name":"Shimon ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shimon-barkama-94783726/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-08 14:46:52.000000","initials":"SB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2019-12-29T00:00:00.000Z","crunchbaseid":"cannassure-therapeutics","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Adam Odesser","creator_email":"adamodesser10@gmail.com","createdate":"2018-05-27T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":"Jenny Sotnik-Talisman","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCzmd2mCQw","date":"Aug 2020","amount":"$235K","source":"https://www.linkedin.com/posts/cannassure_non-dilutive-grant-approval-activity-6695695347726995456-laqa","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"b5fca9d2-a639-4f0f-bd6a-3bb6c2b5b04a","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":235000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODlrLb_CAw","date":"Dec 2018","amount":"Undisclosed","source":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_1728657_0_Txtetaxjxdshwhus8sp&ArticleId=103304","ticker":"CSURE","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$3.2M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":3200000,"valuationnumber":null}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2016","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"CannAssure Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$904PtYEnnt0ZW7cSU62taLiRfnmDsW4i5XsBXHnm6QZCtDIioxb3l8","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$904PtYEnnt0ZW7cSU62taLiRfnmDsW4i5XsBXHnm6QZCtDIioxb3l8","seoabout":"Cannassure develops and commercializes a wide range of effective, high-quality, affordable medical cannabis products and pharmaceutical cannabinoid medicin...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"},{"title":"Medical Cannabis","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Medical Cannabis"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]},{"title":"Healthcare","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Herbals","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Herbals"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development","Medical Cannabis"],"coreTechnology":["Biologicals","Herbals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODlrLb_CAw","date":"Dec 2018","amount":"Undisclosed","source":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_1728657_0_Txtetaxjxdshwhus8sp&ArticleId=103304","ticker":"CSURE","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$3.2M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":3200000,"valuationnumber":null}],"privateequityfunding":[],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCzmd2mCQw","date":"Aug 2020","amount":"$235K","source":"https://www.linkedin.com/posts/cannassure_non-dilutive-grant-approval-activity-6695695347726995456-laqa","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"b5fca9d2-a639-4f0f-bd6a-3bb6c2b5b04a","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":235000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}